# Expanded Access to VAL-083

> **NCT03138629** · — · NO_LONGER_AVAILABLE · sponsor: **Kintara Therapeutics, Inc.**

## Conditions studied

- Cancer

## Interventions

- **DRUG:** VAL-083

## Key facts

- **NCT ID:** NCT03138629
- **Lead sponsor:** Kintara Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03138629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03138629, "Expanded Access to VAL-083". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03138629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*